Clinical Focus

• Neurology
• Stroke
• Cerebrovascular Disease

Professional Education

Graduate & Fellowship Program Affiliations

• Neurology and Neurol Sciences

Internet Links

• Stanford Stroke Center

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information

Current Research Interests

1. Imaging of Cerebral Perfusion with MRI and Xenon CT
2. Determining selection criteria that identify stroke patients who are most likely to benefit from iv tPA
3. Combining iv tPA with intraarterial mechanical thrombectomy for acute stroke
4. Detection of Atrial Fibrillation in patients with stroke and TIA using long term ambulatory cardiac monitoring
5. Prognosis of critically ill neurological patients

Clinical Trials

• DIAS 4 Recruiting
• The Insulin Resistance Intervention after Stroke Trial (IRIS) Recruiting
• CLEAR III Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III Recruiting
• Diagnostic Utility of MRI in Intracerebral Hemorrhage Recruiting
• Diffusion Weighted Imaging Evaluation for Understanding Stroke Evolution Study-2 (DEFUSE-2) Recruiting

Publications

• A comparison of cooling techniques to treat cardiac arrest patients with hypothermia. Finley Caulfield A, Rachabattula S, Eyngorn I, Hamilton SA, Kalimuthu R, Hsia AW, Lansberg MG, Venkatasubramanian C, Baumann JJ, Buckwalter MS, Kumar MA, Castle JS, Wijman CA. Stroke Res Treat. 2011: 2011 690506
• Cost-effectiveness of tissue-type plasminogen activator in the 3- to 4.5-hour time window for acute ischemic stroke. Tung CE, Win SS, Lansberg MG. Stroke. 2011; 42 (8): 2257-62
• Postthrombolysis hemorrhage risk is affected by stroke assessment bias between hemispheres. Audebert HJ, Singer OC, Gotzler B, Vatankhah B, Boy S, Fiehler J, Lansberg MG, Albers GW, Kastrup A, Rovira A, Gass A, Rosso C, Derex L, Kim JS, Heuschmann P. Neurology. 2011; 76 (7): 629-36
• RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Lansberg MG, Lee J, Christensen S, Straka M, De Silva DA, Mlynash M, Campbell BC, Bammer R, Olivot JM, Desmond P, Davis SM, Donnan GA, Albers GW. Stroke. 2011; 42 (6): 1608-14
• Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set. Mlynash M, Lansberg MG, De Silva DA, Lee J, Christensen S, Straka M, Campbell BC, Bammer R, Olivot JM, Desmond P, Donnan GA, Davis SM, Albers GW. Stroke. 2011; 42 (5): 1270-5